✦ LIBER ✦

Safety of Anti-IgE Therapy with Omalizumab in Allergic Patients at Risk of Geohelminth Infection

✍ Scribed by Cooper, P.J.; Lima, F.; Sarinho, E.C.; Ayre, G.; Martin, C.; Fox, H.; Cruz, A.A.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety of anti-immunoglobulin E therapy

✍ A. A. Cruz; F. Lima; E. Sarinho; G. Ayre; C. Martin; H. Fox; P. J. Cooper 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 304 KB

Evaluation of long-term safety of the an

✍ Berger, William; Gupta, Niroo; McAlary, Margaret; Fowler-Taylor, Angel 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 226 KB

Anti-IgE therapy with omalizumab improve

✍ Higgins, B.; Britton, M.; Carrillo, T.; Oshinyemi, K.; Blogg, M. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 140 KB

Safety of anti-IgE treatment with omaliz

✍ Wolfgang Kamin; Matthias Volkmar Kopp; Frank Erdnuess; Uwe Schauer; Stefan Ziele 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 145 KB

Immunogenicity and safety of omalizumab

✍ Somerville, Laura; Bardelas, Jose; Viegas, Andrea; D’Andrea, Peter; Blogg, Marti 📂 Article 📅 2013 🏛 Informa plc 🌐 English ⚖ 176 KB

The Safety of Home Therapy with Subcutan

✍ Liebhaber, M.I.; Dyer, Z. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 51 KB